PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $23,437 | -82.2% | 10,605 | -79.6% | 0.00% | – |
| Q1 2023 | $131,953 | +68.2% | 51,950 | +23.8% | 0.00% | – |
| Q4 2022 | $78,447 | -27.4% | 41,950 | 0.0% | 0.00% | – |
| Q3 2022 | $108,000 | +33.3% | 41,950 | 0.0% | 0.00% | – |
| Q2 2022 | $81,000 | -16.5% | 41,950 | +28.9% | 0.00% | – |
| Q1 2022 | $97,000 | -75.8% | 32,550 | -63.6% | 0.00% | – |
| Q4 2021 | $401,000 | -20.3% | 89,330 | -13.7% | 0.00% | – |
| Q3 2021 | $503,000 | -20.4% | 103,480 | +11.6% | 0.00% | -100.0% |
| Q2 2021 | $632,000 | -1.7% | 92,709 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $643,000 | +8.8% | 91,129 | -3.4% | 0.00% | 0.0% |
| Q4 2020 | $591,000 | +12.4% | 94,385 | -3.0% | 0.00% | 0.0% |
| Q3 2020 | $526,000 | -4.9% | 97,275 | -8.2% | 0.00% | 0.0% |
| Q2 2020 | $553,000 | +64.1% | 105,975 | -0.9% | 0.00% | 0.0% |
| Q1 2020 | $337,000 | -18.4% | 106,975 | +4.4% | 0.00% | 0.0% |
| Q4 2019 | $413,000 | +30.3% | 102,463 | +39.6% | 0.00% | 0.0% |
| Q3 2019 | $317,000 | +32.1% | 73,413 | +22.2% | 0.00% | 0.0% |
| Q2 2019 | $240,000 | -22.8% | 60,063 | +3.6% | 0.00% | 0.0% |
| Q1 2019 | $311,000 | +13.9% | 57,963 | +9.0% | 0.00% | 0.0% |
| Q4 2018 | $273,000 | -49.0% | 53,175 | -3.6% | 0.00% | 0.0% |
| Q3 2018 | $535,000 | +4.1% | 55,150 | +9.4% | 0.00% | 0.0% |
| Q2 2018 | $514,000 | -22.4% | 50,425 | -1.0% | 0.00% | -50.0% |
| Q1 2018 | $662,000 | -17.0% | 50,925 | +14.2% | 0.00% | 0.0% |
| Q4 2017 | $798,000 | -19.4% | 44,575 | +13.0% | 0.00% | -33.3% |
| Q3 2017 | $990,000 | +40.4% | 39,450 | +34.9% | 0.00% | 0.0% |
| Q2 2017 | $705,000 | +27.5% | 29,250 | -1.7% | 0.00% | -25.0% |
| Q1 2017 | $553,000 | +20.5% | 29,750 | +1.0% | 0.00% | +33.3% |
| Q4 2016 | $459,000 | +13.9% | 29,450 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $403,000 | +14.8% | 29,450 | +11.3% | 0.00% | +33.3% |
| Q2 2016 | $351,000 | -9.5% | 26,450 | +1.7% | 0.00% | +200.0% |
| Q1 2016 | $388,000 | – | 26,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|